Systematic review to inform the development of a community pharmacy-based intervention for people affected by dementia

Dann-Reed, Eleanor; Poland, Fiona; Wright, David

doi:10.1111/ijpp.12586

Cited by 2 publications

(1 citation statement)

References 43 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, assessing the effectiveness of community pharmacists by monitoring caregiver burden has been initiated [ 27 ]. However, whether community pharmacist interventions contribute to a reduction in the burden of caregiving is not fully understood [ 28 ]. Therefore, the objectives of the current study were to examine (1) the feasibility of a developed community pharmacist working procedure in dementia care and (2) the expected impact of pharmacist intervention on care burden.…”

Section: Introductionmentioning

confidence: 99%

Impact of interventions by a community pharmacist on care burden for people with dementia: development and randomized feasibility trial of an intervention protocol

Nanaumi

Yoshitani

Onda

2022

Pilot Feasibility Stud

View full text Add to dashboard Cite

Background Traditionally, the role of pharmacists has been to manage and monitor pharmacotherapy for patients with dementia. However, additional intervention by community pharmacists to collect and share patient information with other professionals may help reduce the care burden among caregivers. The aims of this study were to examine (1) the feasibility of a designed community pharmacist working procedure in dementia care and (2) the expected impact of pharmacist intervention on care burden. Methods This was a randomized, open-label, parallel-group feasibility study, involving eight Nara City pharmaceutical association member pharmacies that provided consent to participate. These pharmacies were assigned to an intervention group or a control group at a 1:1 ratio. The subjects were patients with dementia and their primary caregivers that visited the participating pharmacies and provided consent to participate. Pharmacists in the intervention group actively collected information from the patients’ family physicians and care managers and intervened to address medication-related problems, while those in the control group only performed their normal duties. The primary endpoint was a change in the caregiver’s score on the Japanese version of Zarit Caregiver Burden interview (J-ZBI) from the baseline to after 5 months of follow-up. The changes in mean J-ZBI scores from the beginning to the end of the study period of the two groups were compared. Results Obtaining consent from caregivers was certainly difficult, but possible. Pharmacists managed to fill out the survey form while practising pharmaceutical care. Totally, nine patients and nine caregivers in the intervention group and nine patients and eight caregivers in the control group completed the study. The changes in J-ZBI scores could be calculated for seven cases in the intervention group and five cases in the control group. The J-ZBI scores were found to decrease by 1.0 in the intervention group and increase by 3.0 in the control group. Conclusions The protocol presented was considered feasible, but, the intervention process needs to be simplified in order to conduct a large study. Also, improvements are needed in the various survey forms and in the explanatory documents for caregivers. Although the sample size was small, the effect sizes suggested that community pharmacist interventions for patient with dementia may reduce the care burden for caregivers. Trial registration UMIN000039949 (registration date: 1 April 2020, retrospectively registered)

show abstract

Section: Introductionmentioning

confidence: 99%

Impact of interventions by a community pharmacist on care burden for people with dementia: development and randomized feasibility trial of an intervention protocol

Nanaumi

Yoshitani

Onda

2022

Pilot Feasibility Stud

View full text Add to dashboard Cite

show abstract

Community pharmacists’ knowledge of, and role in, managing anticholinergic burden among patients with dementia in primary care: a cross-sectional survey study

Shawaqfeh,

Hughes,

McGuinness

et al. 2024

Int J Clin Pharm

View full text Add to dashboard Cite

Background Anticholinergic medications and associated anticholinergic burden can impair cognitive function and increase mortality rates in patients with dementia. Aim To explore community pharmacists’ knowledge of anticholinergic burden and perceptions of their role in anticholinergic burden management amongst patients with dementia. Method A self-administered, postal questionnaire was distributed to all registered community pharmacies in Northern Ireland (n = 526) on two occasions (October and November 2022). The questionnaire comprised four sections: (1) demographics associated with pharmacists and pharmacies, (2) contact between community pharmacists and patients with dementia/their carers, and types of medication-related queries received by pharmacists, (3) understanding and knowledge about anticholinergic burden, and (4) community pharmacist role in management of anticholinergic burden in patients with dementia. Data were analysed descriptively using Stata v17. Results A response rate of 15.2% (80/526) was achieved. Most contact was with patients with dementia/carers in their own homes. Community pharmacists lacked knowledge about anticholinergic burden in dementia, did not use any anticholinergic burden scales in their practice (n = 77, 96.3%), and rarely discussed anticholinergic burden with patients, carers (n = 60, 75.0%), or other healthcare professionals (n = 42, 52.5%). However, they were positive about their role in future interventions and saw value in managing anticholinergic burden in patients with dementia as part of a multidisciplinary primary healthcare team (n = 67; 83.3%). Conclusion Despite the low response rate, the study findings have highlighted community pharmacists’ willingness to contribute to the management of anticholinergic burden in patients with dementia. Further research is required to understand how this can be achieved.

show abstract

Systematic review to inform the development of a community pharmacy-based intervention for people affected by dementia

Cited by 2 publications

References 43 publications

Impact of interventions by a community pharmacist on care burden for people with dementia: development and randomized feasibility trial of an intervention protocol

Impact of interventions by a community pharmacist on care burden for people with dementia: development and randomized feasibility trial of an intervention protocol

Community pharmacists’ knowledge of, and role in, managing anticholinergic burden among patients with dementia in primary care: a cross-sectional survey study

Contact Info

Product

Resources

About